CD37 Protein (AA 113-240) (His tag)

N° du produit ABIN7504265

Détail du produit

Antigène: CD37 (TSPAN26) (Tetraspanin 26 (TSPAN26))

Type de proteíne: Recombinant

Attributs du protein: AA 113-240

Origine: Humain

Source: HEK-293 Cells

Purification/Conjugué: Cette CD37 protéine est marqué à la His tag.

Fonction: Human CD37 Protein

Séquence: Ala113-Asn240

Attributs du produit: Recombinant Human CD37 Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Ala113-Asn240.

Pureté: > 95 % as determined by Tris-Bis PAGE

Stérilité: 0.22 μm filtered

niveau d'endotoxine: Less than 1EU per μg by the LAL method.

Information d'application

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.

Buffer: Lyophilized from 0.22 μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.

Stock: -20 °C,-80 °C

Stockage commentaire: -20 to -80°C for 12 months as supplied from date of receipt., -80°C for 3-6 months after reconstitution., 2-8°C for 2-7 days after reconstitution., Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.

Date de péremption: 12 months

Détail du antigène

Antigène: CD37 (TSPAN26) (Tetraspanin 26 (TSPAN26))

Autre désignation: CD37 (TSPAN26 Produits)

Synonymes: Tspan26 Protein, GP52-40 Protein, TSPAN26 Protein, CD37 antigen Protein, CD37 molecule Protein, Cd37 Protein, CD37 Protein

Sujet: CD37 is a tetraspanin expressed prominently on the surface of B cells. It is an attractive molecular target exploited in the immunotherapy of B cell-derived lymphomas and leukemia. Currently, several monoclonal antibodies targeting CD37 as well as chimeric antigen receptor-based immunotherapies are being developed and investigated in clinical trials. Given the unique role of CD37 in the biology of B cells, it seems that CD37 constitutes more than a docking point for monoclonal antibodies, and targeting this molecule may provide additional benefit to relapsed or refractory patients.

Poids moléculaire: 15.72 kDa. Due to glycosylation, the protein migrates to 25-40 kDa based on Tris-Bis PAGE result.

Pathways: Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response